Editorials

Molecular assessment and the current limits of post-transplant prognostication for chronic myelomonocytic leukemia

Division of Hematologic Malignancies, Dana-Farber Cancer Institute 450 Brookline Ave., Boston MA 02215
Division of Hematologic Malignancies, Dana-Farber Cancer Institute 450 Brookline Ave., Boston MA 02215
Vol. 108 No. 1 (2023): January, 2023 https://doi.org/10.3324/haematol.2022.280960